Stay updated with breaking news from Biologics licence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Australian share market ignored the softer lead from US markets overnight to test new highs in early trading, before late afternoon selling pushed the index into the red. ....
OCGN Stock: Seems Unattractive With Regulatory Uncertainties investorplace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorplace.com Daily Mail and Mail on Sunday newspapers.
URL copied No EUA to Covaxin in USA: FDA recommends Biologics Licence Application route for approval In setback that could potentially delay the launch of Bharat Biotech s COVID-19 vaccine Covaxin in USA, the Food and Drug Administration there has recommended Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixing hopes of Emergency Use Authorisation (EUA). Ocugen in a statement on Thursday announced that as recommended by the FDA, it will pursue submission of a biologics licence application (BLA) for Covaxin. BLA is a full approval mechanism by the FDA for drugs and vaccines. The development may delay the Covaxin launch in the US, Ocugen said. ....